- Program status
- Peptide API raw material
- Product context
- Semaglutide is a long-acting GLP-1 analogue with 94% sequence homology to human GLP-1. This API page presents the reference molecular identity and sourcing boundary, not a finished dosage form or treatment claim. Supplied form, specification, batch evidence, and target-market eligibility are confirmed per project.
- Portfolio specification
- The public portfolio specification is ≥99% by HPLC. For each peptide API raw material, the applicable method, sample identity, batch result, and document status are confirmed through the corresponding CoA and project record.
- Molecular formula
- C187H291N45O59
- CAS
- 910463-68-2
- Average molecular weight
- 4113.58 g/mol
Metabolic peptide API and raw material focus
One Focused Field, Molecules Reviewed Separately
LUMIRABIO supports B2B review of Semaglutide, Tirzepatide, and investigational Retatrutide peptide API raw materials within one metabolic-peptide field. Each dossier keeps molecular identity, development status, specification, evidence, and supply conditions distinct.
Focused molecule scopeThree molecules currently covered
Batch-specific evidenceMethod and scope govern
Qualified B2B reviewMarket and use confirmed
Confirm the identity before discussing supply.
The public facts below identify the reference peptide. Supplied form, counter-ion, grade, specification, site, batch, documents, timing, and target-market eligibility are confirmed per inquiry.
Portfolio specification
≥99%By product-appropriate HPLC
The public portfolio specification is ≥99% by HPLC. For each peptide API raw material, the applicable method, sample identity, batch result, and document status are confirmed through the corresponding CoA and project record.
Material definition
Formal specifications and batch records connect the reference molecule to the exact raw material included in the proposal.
Three peptide API raw material dossiers
Confirm the molecule first, then align the raw material specification, quantity, documents, and delivery route.
- Program status
- Peptide API raw material
- Product context
- Tirzepatide is a synthetic, acylated 39-residue peptide with agonist activity at the GIP and GLP-1 receptors. Its C20 fatty-diacid modification supports albumin binding. This API page separates reference identity from the supplied form, specification, batch evidence, and market-specific review.
- Portfolio specification
- The public portfolio specification is ≥99% by HPLC. For each peptide API raw material, the applicable method, sample identity, batch result, and document status are confirmed through the corresponding CoA and project record.
- Molecular formula
- C225H348N48O68
- CAS
- 2023788-19-2
- Average molecular weight
- 4813.53 g/mol
Investigational acylated peptide
Investigational APIRetatrutide
Metabolic research
03- Program status
- Investigational API
- Product context
- Retatrutide is an investigational single peptide with agonist activity at the GIP, GLP-1, and glucagon receptors. It remains under clinical development; this page supports qualified institutional review of reference identity, proposed supplied form, documentation, destination, and project eligibility only.
- Portfolio specification
- The public portfolio specification is ≥99% by HPLC. For each peptide API raw material, the applicable method, sample identity, batch result, and document status are confirmed through the corresponding CoA and project record.
- Molecular formula
- C221H342N46O68
- CAS
- Confirm exact form
- Average molecular weight
- Approximately 4731 g/mol
One coordinated review path
Move from molecule selection to an order-specific supply decision.
The same four workstreams connect molecule selection, batch evidence, manufacturing coordination, and delivery planning for each inquiry.
- 01
Specification review
Confirm form, target specification, quantity, and intended market.
- 02
Batch evidence
Match method, sample identity, result, issuer, and applicable CoA.
- 03
Manufacturing coordination
Align route, scale, responsible site, and available capacity.
- 04
Supply planning
Confirm packaging, documents, Los Angeles or New Jersey eligibility, route, and timing.